Hemochromatosis and iron-overload screening in a racially diverse population

被引:567
作者
Adams, PC
Reboussin, DM
Barton, JC
McLaren, CE
Eckfeldt, JH
McLaren, GD
Dawkins, FW
Acton, RT
Harris, EL
Gordeuk, VR
Leiendecker-Foster, C
Speechley, M
Snively, BM
Holup, JL
Thomson, E
Sholinsky, P
Acton, RT
Barton, JC
Dixon, D
Rivers, CA
Tucker, D
Ware, JC
McLaren, CE
McLaren, GD
Anton-Culver, H
Baca, JA
Bent, TC
Brunner, LC
Dao, MM
Jorgensen, KS
Kuniyoshi, J
Le, HD
Masatsugu, MK
Meyskens, FL
Morohashi, D
Nguyen, HP
Panagon, SN
Phung, C
Raymundo, V
Ton, T
Walker, AP
Wenzel, LB
Ziogas, A
Adams, PC
Bloch, E
Chakrabarti, S
Fleischhauer, A
Harrison, H
Jia, K
Larson, S
机构
[1] London Hlth Sci Ctr, Dept Med, London, ON N6A 5A5, Canada
[2] Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27103 USA
[3] So Iron Disorders Ctr, Birmingham, AL USA
[4] Univ Calif Irvine, Dept Med, Div Hematol & Oncol, Irvine, CA 92717 USA
[5] Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92717 USA
[6] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN USA
[7] Vet Affairs Long Beach Healthcare Syst, Long Beach, CA USA
[8] Howard Univ, Dept Med, Washington, DC 20059 USA
[9] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA
[10] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[11] Univ Alabama Birmingham, Dept Epidemiol & Int Hlth, Birmingham, AL 35294 USA
[12] Kaiser Permanente Ctr Hlth Res, Portland, OR USA
[13] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada
[14] Kaiser Permanente Ctr Hlth Res, Honolulu, HI USA
[15] NHGRI, Bethesda, MD 20892 USA
[16] NHLBI, Epidemiol & Biometry Program, Bethesda, MD 20892 USA
关键词
D O I
10.1056/NEJMoa041534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Iron overload and hemochromatosis are common, treatable conditions. HFE genotypes, levels of serum ferritin, transferrin saturation values, and self-reported medical history were studied in a multiethnic primary care population. METHODS: Participants were recruited from primary care practices and blood-drawing laboratories. Blood samples were tested for transferrin saturation, serum ferritin, and C282Y and H63D mutations of the HFE gene. Before genetic screening, participants were asked whether they had a history of medical conditions related to iron overload. RESULTS: Of the 99,711 participants, 299 were homozygous for the C282Y mutation. The estimated prevalence of C282Y homozygotes was higher in non-Hispanic whites (0.44 percent) than in Native Americans (0.11 percent), Hispanics (0.027 percent), blacks (0.014 percent), Pacific Islanders (0.012 percent), or Asians (0.000039 percent). Among participants who were homozygous for the C282Y mutation but in whom iron overload had not been diagnosed (227 participants), serum ferritin levels were greater than 300 microg per liter in 78 of 89 men (88 percent) and greater than 200 microg per liter in 79 of 138 women (57 percent). Pacific Islanders and Asians had the highest geometric mean levels of serum ferritin and mean transferrin saturation despite having the lowest prevalence of C282Y homozygotes. There were 364 participants in whom iron overload had not been diagnosed (29 C282Y homozygotes) who had a serum ferritin level greater than 1000 microg per liter. Among men, C282Y homozygotes and compound heterozygotes were more likely to report a history of liver disease than were participants without HFE mutations. CONCLUSIONS: The C282Y mutation is most common in whites, and most C282Y homozygotes have elevations in serum ferritin levels and transferrin saturation. The C282Y mutation does not account for high mean serum ferritin levels and transferrin saturation values in nonwhites.
引用
收藏
页码:1769 / 1778
页数:10
相关论文
共 33 条
[1]   Alcoholism in hereditary hemochromatosis revisited: Prevalence and clinical consequences among homozygous siblings [J].
Adams, PC ;
Agnew, S .
HEPATOLOGY, 1996, 23 (04) :724-727
[2]  
Adams PC, 1997, HEPATOLOGY, V25, P162, DOI 10.1002/hep.510250130
[3]   Hemochromatosis mutations in the general population: iron overload progression rate [J].
Andersen, RV ;
Tybjaerg-Hansen, A ;
Appleyard, M ;
Birgens, H ;
Nordestgaard, BG .
BLOOD, 2004, 103 (08) :2914-2919
[4]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[5]  
Åsberg A, 2001, SCAND J GASTROENTERO, V36, P1108
[6]   HFE genotype in patients with hemochromatosis and other liver diseases [J].
Bacon, BR ;
Olynyk, JK ;
Brunt, EM ;
Britton, RS ;
Wolff, RK .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (12) :953-962
[7]   Hemochromatosis: Diagnosis and management [J].
Bacon, BR .
GASTROENTEROLOGY, 2001, 120 (03) :718-725
[8]   Genotypic and phenotypic heterogeneity of African Americans with primary iron overload [J].
Barton, JC ;
Acton, RT ;
Rivers, CA ;
Bertoli, LF ;
Gelbart, T ;
West, C ;
Beutler, E .
BLOOD CELLS MOLECULES AND DISEASES, 2003, 31 (03) :310-319
[9]   Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis [J].
Beaton, M ;
Guyader, D ;
Deugnier, Y ;
Moirand, R ;
Chakrabarti, S ;
Adams, P .
HEPATOLOGY, 2002, 36 (03) :673-678
[10]   Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA [J].
Beutler, E ;
Felitti, VJ ;
Koziol, JA ;
Ho, NJ ;
Gelbart, T .
LANCET, 2002, 359 (9302) :211-218